TaiwanJ Pharmaceuticals Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-24.34	-22.34	-6.05	-92.47	-12.42	Upgrade
Depreciation & Amortization	1.61	1.89	2.01	76.47	1.16	Upgrade
Stock-Based Compensation	0.21	0.45	1.38	0.59	-0.01	Upgrade
Provision & Write-off of Bad Debts	-	-	-	10.75	-	Upgrade
Other Operating Activities	-0.77	-2.1	-2.52	-0.49	-0.04	Upgrade
Change in Accounts Receivable	0.03	0.19	4.61	-15.36	-	Upgrade
Change in Accounts Payable	-0.71	-0.2	-0.89	-0.14	0.11	Upgrade
Change in Other Net Operating Assets	-0.2	-0.52	0.63	-0.42	1.16	Upgrade
Operating Cash Flow	-24.17	-22.62	-0.82	-21.07	-10.05	Upgrade
Capital Expenditures	-0.29	-	-1.44	-1.23	-	Upgrade
Investment in Securities	40	-40	-	-	-	Upgrade
Other Investing Activities	6.14	2.1	1.09	0.67	0.04	Upgrade
Investing Cash Flow	45.85	-37.9	-0.35	-0.56	0.04	Upgrade
Long-Term Debt Repaid	-0.74	-0.7	-0.69	-0.56	-0.56	Upgrade
Net Debt Issued (Repaid)	-0.74	-0.7	-0.69	-0.56	-0.56	Upgrade
Issuance of Common Stock	-	50	-	-	-	Upgrade
Financing Cash Flow	-0.74	49.3	-0.69	-0.56	-0.56	Upgrade
Foreign Exchange Rate Adjustments	-0.72	-	-	-	-	Upgrade
Net Cash Flow	20.22	-11.22	-1.86	-22.19	-10.57	Upgrade
Free Cash Flow	-24.46	-22.62	-2.26	-22.3	-10.05	Upgrade
Free Cash Flow Margin	-	-	-9.95%	-145.22%	-45.56%	Upgrade
Free Cash Flow Per Share	-0.30	-0.30	-0.03	-0.30	-0.13	Upgrade
Cash Interest Paid	0.05	0.01	0.02	0.01	0.01	Upgrade
Cash Income Tax Paid	-0.16	-	2.27	-	2.11	Upgrade
Levered Free Cash Flow	-14.98	-15.04	2.15	10.41	-3.68	Upgrade
Unlevered Free Cash Flow	-14.95	-15.03	2.17	10.42	-3.67	Upgrade
Change in Working Capital	-0.88	-0.53	4.35	-15.91	1.27	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.